$100 million investment into cancer treatment
IN A rich announcement for cancer patients in need of financial help, the Federal Government has invested $100 million into the Pharmaceutical Benefits Scheme which will add five new cancer listings and treatments.
The unveiling of a host of medications added to the PBS will ensure patients are afforded more accessible options to treatments of various cancers; including malignant melanomas that cannot be surgically removed and acute myeloid leukaemia.
Member for Dawson George Christensen praised the investment, and said patients would now be provided access to “lifesaving and life-changing medicines quicker than ever before”.
“From December 1, eligible patients throughout the region with certain forms of leukaemia, advanced tumours of the intestine and pancreas, melanoma, bowel cancer and ovarian cancer will save up to $100,000 a year.”
This October a report by the Department of Health stated that melanoma rates in Queensland were the highest in the country, seeing a 13 per cent increase among adults aged 45 to 64.
The combination of medications known as Opdivo and Yervoy addresses a high and unmet clinical need for this debilitating condition, according to the Pharmaceutical Benefits Advisory Committee.
The collaboration of the treatments may improve outcomes for patients, with costs exceeding $100,000 a course.